Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 12, 2006The PREVAIL study showed that in acute ischemic stroke patients treated with Lovenox, the risk of having a VTE was lowered by a significant 43% with no statistically significant increase in clinically important bleedings when compared to UFH
-
Dec 8, 2006
-
Dec 5, 2006First Rimonabant Trial with HbA1c as a Primary Endpoint
-
Oct 30, 2006Comparative Clinical Trial Results Announced for the Treatment of Nasolabial Folds at the 2006 American Society of Dermatologic Surgery (ASDS) Annual Meeting
-
Oct 18, 2006Taxotere(R)-based regimen demonstrates a significantly longer progression free survival and 29 percent reduction in the risk of mortality in patients with inoperable locally advanced head and neck cancer
-
Oct 18, 2006New formulation provides non-impairing symptom relief for pediatric populations
-
Aug 17, 2006Expands PLAVIX Indication to include patients with any acute coronary syndromes (ACS)
-
Aug 14, 200612 Million Men in U.S. at Risk for this Fragile Bone Disease
-
Jul 12, 2006Results extending the role of AMBIEN CR in the treatment of insomnia presented at the 2006 CINP (Collegium Internationale Neuro-Psychopharmacologicum) 25th Biennial Congress
-
Jun 20, 2006Thrombosis Management Clinical Effectiveness Initiative(R) (CEI) Study Demonstrates Cost Savings of More Than $1,000 Per Discharge With Enoxaparin
-
Jun 10, 2006Type 2 Diabetes Patients Using a New Insulin Dosing Strategy Achieved a Mean A1C of 6.6% after 24 Weeks of Combination Therapy with Rapid-Acting Apidra(R)
-
Jun 3, 2006Findings show demonstrated overall survival with less febrile neutropenia for Taxotere(R) versus vinca-alkaloid regimens
-
May 30, 2006430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting's scientific sessions
-
May 16, 2006Adam West and his wife team up to raise awareness of enlarged prostate due to BPH, the most common prostate problem in men
-
Mar 23, 2006TAXOTERE(R)-based regimen demonstrates a 23% reduction in the risk of mortality in patients with advanced stomach cancer
-
Mar 12, 2006Certain subgroups may benefit from dual therapy, for others it should be avoided
-
Feb 28, 2006New prandial insulin with the OptiClik(R) delivery system can work with longer-acting insulins, such as basal insulin Lantus(R), providing a complementary approach to glucose control
-
Feb 14, 2006Study Shows Rimonabant Maintains Improvements in Multiple Cardiometabolic Risk Factors for Up to Two Years
-
Jan 18, 2006Filing for STEMI Indication Also Submitted in Europe
-
Jan 4, 2006Lawsuit Alleges Advertising for Once-a-Month Osteoporosis Drug Misleads Physicians and Consumers
-
Oct 7, 2005
-
Jun 23, 2005
-
Jan 25, 2005